Brown & Brown BRO
- Market cap
- $24.4B
- PE
- 21.8×
- 10y median 29.1×
- Forward PE
- 15.7×
- 10y median 24.2×
- Price to sales
- 3.6×
- EV/EBIT
- 16.1×
- Revenue, 12 months
- $6.8B
- +34% on a year ago
- Net margin
- 17.7%
- Free cash flow yield
- 5.9%
Brown & Brown trades at 21.8× trailing earnings, cheaper than 93% of the last ten years. Revenue was $6.8B over the last twelve months, up 34% on a year earlier with a 18% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.1B+15% | $1B+14% | $1.3B+13% | $1.2B+13% | $1.2B+11% | $1.2B+15% | $1.4B+12% | $1.3B+9% | $1.6B+35% | $1.6B+36% | $1.9B+35% | $1.7B+30% | |
| $289.8M+12% | $403M+68% | $412M+21% | $395M+31% | $367M+27% | $321M−20% | $473M+15% | $362M−8% | $411M+12% | $421M+31% | $632M+34% | $483M+33% | |
| Interest expense | $47.5M+15% | $47M+4% | $48M+3% | $49M+2% | $50M+5% | $46M−2% | $46M−4% | $51M+4% | $100M+100% | $100M+117% | $99M+115% | $100M+96% |
| Pre-tax income | $242.3M+11% | $355.1M+83% | $364M+24% | $346M+36% | $317M+31% | $275M−23% | $427M+17% | $311M−10% | $311M−2% | $321M+17% | $533M+25% | $383M+23% |
| $66.4M+17% | $85.8M+75% | $71M+22% | $87M+36% | $78M+18% | $64M−25% | $93M+31% | $77M−12% | $82M+5% | $53M−17% | $106M+14% | $94M+22% | |
| Net income | $175.9M+9% | $268.7M+85% | $293M+24% | $257M+35% | $234M+33% | $210M−22% | $331M+13% | $231M−10% | $227M−3% | $264M+26% | $426M+29% | $288M+25% |
| $0.62+9% | $0.95+86% | $1.02+23% | $0.90+34% | $0.81+31% | $0.72−24% | $1.15+13% | $0.78−13% | $0.68−16% | $0.77+7% | $1.06−8% | $0.84+8% | |
| 281.3M+1% | 280M+0% | 283M+1% | 283M+1% | 284M+1% | 287M+3% | 285M+1% | 293M+4% | 332M+17% | 340M+19% | 337M+18% | 334M+14% |
Operating income: 69 periods, Q2 FY09 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 8 periods, Q2 FY09 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 17 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $1.8B | $1.7B to $1.8B | $1.09 | $1.06 to $1.13 | 14 |
| Q4 FY26 | $1.7B | $1.6B to $1.7B | $0.94 | $0.91 to $1.00 | 13 |
| Q1 FY27 | $2B | $1.9B to $2B | $1.48 | $1.45 to $1.54 | 5 |
| Q2 FY27 | $1.7B | $1.7B to $1.8B | $1.15 | $1.12 to $1.20 | 5 |
| Q3 FY27 | $1.8B | $1.8B to $1.9B | $1.20 | $1.17 to $1.25 | 5 |
| Q4 FY27 | $1.7B | $1.7B to $1.8B | $1.04 | $1.02 to $1.08 | 5 |
| Q1 FY28 | $2.1B | $2B to $2.1B | $1.63 | $1.59 to $1.69 | 6 |
| Q2 FY28 | $1.8B | $1.8B to $1.9B | $1.25 | $1.23 to $1.31 | 6 |
Peers
Companies in Insurance - Brokers nearest Brown & Brown's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BROBrown & Brown | $24.4B | 21.8× | 29.1× | 15.7× | 3.6× | +34% | 17.7% |
| WTWWillis Towers Watson Public | $30.2B | 19.9× | 26.0× | 15.5× | 3.0× | +3% | 15.5% |
| ERIEErie Indemnity | $13.3B | 23.0× | 31.6× | n/m | 3.2× | +4% | 14.0% |
| RYANRyan Specialty | $11.2B | 60.7× | 92.3× | n/m | 3.5× | +14% | 3.1% |
| AONAon | $64.4B | 16.7× | 27.9× | 15.8× | 3.7× | +5% | 22.3% |
| AJGArthur J. Gallagher | $68.7B | 44.5× | 33.5× | 19.2× | 4.4× | +26% | 10.0% |
| ACTEnact | $6.6B | 10.1× | 7.8× | n/m | 5.3× | +2% | 54.5% |
| MRSHMarsh & McLennan Companies | $93.9B | 23.7× | 27.2× | 17.6× | 3.3× | +8% | 14.2% |
| HGTYHagerty | $5.4B | 260× | 50.9× | n/m | 3.7× | +8% | 1.8% |
| CRVLCorvel | $4.2B | 37.3× | 38.1× | n/m | 4.3× | +7% | 11.7% |
| NPNeptune Insurance | $3.9B | 91.7× | 126× | n/m | 19.9× | +34% | 22.7% |
| Peer median | $12.2B | 30.5× | 32.5× | 16.7× | 3.7× | +7% | 14.1% |
Investors who own it
Investors we follow who held Brown & Brown at the end of Jun 30, 2026, from their 13F filings.
- François RochonGiverny Capital1.6% of portfoliotrimmed
- Tom GaynerMarkel Group0.0% of portfolio
- Baillie GiffordBaillie Gifford0.0% of portfoliotrimmed
More on Brown & Brown
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 13Insurance brokers with the highest free cash flow yield
- #3of 19Insurance brokers with the fastest revenue growth
- #4of 17Insurance brokers with the highest profit margins
- #4of 14Insurance brokers with the lowest PE ratio
- #6of 15Insurance brokers with the lowest EV/EBIT
- #7of 11Insurance brokers with the fastest earnings growth
Its groups
About
- Industry
- Insurance - Brokers
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .